Review of allelic loss and gain in prostate cancer

G. S. Bova, William B Isaacs

Research output: Contribution to journalArticle

Abstract

There are three nearly ubiquitous genomic "imbalances" in prostate cancer cells: 1 ) loss of sequences from the short arm of chromosomes 8, 2) loss of sequences from the long arm of chromosome 13q, and 3) gain of sequences on the long arm of chromosome 8, particularly in advanced disease. Candidate tumor suppressor genes and oncogenes affected by this trio of consistent changes include the c-myc gene on chromosome 8q24. the RB gene at 13ql4, and potentially multiple novel genes on the short arm of chromosome 8, with a gene located more proximally potentially involved in tumor initiation and a gene or genes located more distally involved in tumor progression. Loss of regions of chromosomes 2q, 5q, 6q, 7p and 7q, 9p, 10p and lOq, 16q, 17p and 17q, and 18q, and gain of regions of Iq, 2p, 3p and 3q, 7p and 7q, 1 Ip, 17q, and Xq have also been detected in the range of 25-50% of tumors studied. Analysis of candidate tumor suppressor genes in these regions is still in its early stages. Similarly, potential oncogenes on a series of chromosomal arms which undergo frequent amplification remain essentially uncharacterized. The basic outline of the chromosomal aberrations in prostate cancer has been well established; the details of the story remain to be filled in. This paper reviews the advantages and disadvantages of various techniques for detection of genomic loss and gain in prostate cancer cells, and reviews published reports of loss and gain in prostate cancer, focusing primarily on reports using microsatellite analysis, Southern analysis, and comparative genomic hybridization. Fluorescence in situ hybridization (FISH) based analyses of selected regions are also reviewed.

Original languageEnglish (US)
Pages (from-to)338-346
Number of pages9
JournalWorld Journal of Urology
Volume14
Issue number5
StatePublished - 1996

Fingerprint

Loss of Heterozygosity
Prostatic Neoplasms
Chromosomes, Human, Pair 8
Genes
Tumor Suppressor Genes
Oncogenes
Chromosomes
Neoplasms
myc Genes
Chromosomes, Human, Pair 3
Comparative Genomic Hybridization
Chromosomes, Human, Pair 2
Fluorescence In Situ Hybridization
Chromosome Aberrations
Microsatellite Repeats

ASJC Scopus subject areas

  • Urology

Cite this

Review of allelic loss and gain in prostate cancer. / Bova, G. S.; Isaacs, William B.

In: World Journal of Urology, Vol. 14, No. 5, 1996, p. 338-346.

Research output: Contribution to journalArticle

@article{ea670eb5425c49458e5ee972e9b67261,
title = "Review of allelic loss and gain in prostate cancer",
abstract = "There are three nearly ubiquitous genomic {"}imbalances{"} in prostate cancer cells: 1 ) loss of sequences from the short arm of chromosomes 8, 2) loss of sequences from the long arm of chromosome 13q, and 3) gain of sequences on the long arm of chromosome 8, particularly in advanced disease. Candidate tumor suppressor genes and oncogenes affected by this trio of consistent changes include the c-myc gene on chromosome 8q24. the RB gene at 13ql4, and potentially multiple novel genes on the short arm of chromosome 8, with a gene located more proximally potentially involved in tumor initiation and a gene or genes located more distally involved in tumor progression. Loss of regions of chromosomes 2q, 5q, 6q, 7p and 7q, 9p, 10p and lOq, 16q, 17p and 17q, and 18q, and gain of regions of Iq, 2p, 3p and 3q, 7p and 7q, 1 Ip, 17q, and Xq have also been detected in the range of 25-50{\%} of tumors studied. Analysis of candidate tumor suppressor genes in these regions is still in its early stages. Similarly, potential oncogenes on a series of chromosomal arms which undergo frequent amplification remain essentially uncharacterized. The basic outline of the chromosomal aberrations in prostate cancer has been well established; the details of the story remain to be filled in. This paper reviews the advantages and disadvantages of various techniques for detection of genomic loss and gain in prostate cancer cells, and reviews published reports of loss and gain in prostate cancer, focusing primarily on reports using microsatellite analysis, Southern analysis, and comparative genomic hybridization. Fluorescence in situ hybridization (FISH) based analyses of selected regions are also reviewed.",
author = "Bova, {G. S.} and Isaacs, {William B}",
year = "1996",
language = "English (US)",
volume = "14",
pages = "338--346",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Review of allelic loss and gain in prostate cancer

AU - Bova, G. S.

AU - Isaacs, William B

PY - 1996

Y1 - 1996

N2 - There are three nearly ubiquitous genomic "imbalances" in prostate cancer cells: 1 ) loss of sequences from the short arm of chromosomes 8, 2) loss of sequences from the long arm of chromosome 13q, and 3) gain of sequences on the long arm of chromosome 8, particularly in advanced disease. Candidate tumor suppressor genes and oncogenes affected by this trio of consistent changes include the c-myc gene on chromosome 8q24. the RB gene at 13ql4, and potentially multiple novel genes on the short arm of chromosome 8, with a gene located more proximally potentially involved in tumor initiation and a gene or genes located more distally involved in tumor progression. Loss of regions of chromosomes 2q, 5q, 6q, 7p and 7q, 9p, 10p and lOq, 16q, 17p and 17q, and 18q, and gain of regions of Iq, 2p, 3p and 3q, 7p and 7q, 1 Ip, 17q, and Xq have also been detected in the range of 25-50% of tumors studied. Analysis of candidate tumor suppressor genes in these regions is still in its early stages. Similarly, potential oncogenes on a series of chromosomal arms which undergo frequent amplification remain essentially uncharacterized. The basic outline of the chromosomal aberrations in prostate cancer has been well established; the details of the story remain to be filled in. This paper reviews the advantages and disadvantages of various techniques for detection of genomic loss and gain in prostate cancer cells, and reviews published reports of loss and gain in prostate cancer, focusing primarily on reports using microsatellite analysis, Southern analysis, and comparative genomic hybridization. Fluorescence in situ hybridization (FISH) based analyses of selected regions are also reviewed.

AB - There are three nearly ubiquitous genomic "imbalances" in prostate cancer cells: 1 ) loss of sequences from the short arm of chromosomes 8, 2) loss of sequences from the long arm of chromosome 13q, and 3) gain of sequences on the long arm of chromosome 8, particularly in advanced disease. Candidate tumor suppressor genes and oncogenes affected by this trio of consistent changes include the c-myc gene on chromosome 8q24. the RB gene at 13ql4, and potentially multiple novel genes on the short arm of chromosome 8, with a gene located more proximally potentially involved in tumor initiation and a gene or genes located more distally involved in tumor progression. Loss of regions of chromosomes 2q, 5q, 6q, 7p and 7q, 9p, 10p and lOq, 16q, 17p and 17q, and 18q, and gain of regions of Iq, 2p, 3p and 3q, 7p and 7q, 1 Ip, 17q, and Xq have also been detected in the range of 25-50% of tumors studied. Analysis of candidate tumor suppressor genes in these regions is still in its early stages. Similarly, potential oncogenes on a series of chromosomal arms which undergo frequent amplification remain essentially uncharacterized. The basic outline of the chromosomal aberrations in prostate cancer has been well established; the details of the story remain to be filled in. This paper reviews the advantages and disadvantages of various techniques for detection of genomic loss and gain in prostate cancer cells, and reviews published reports of loss and gain in prostate cancer, focusing primarily on reports using microsatellite analysis, Southern analysis, and comparative genomic hybridization. Fluorescence in situ hybridization (FISH) based analyses of selected regions are also reviewed.

UR - http://www.scopus.com/inward/record.url?scp=0030342130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030342130&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 338

EP - 346

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 5

ER -